Search hospitals > Illinois > Galesburg

Illinois CancerCare-Galesburg

Claim this profile
Galesburg, Illinois 61401
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
410 reported clinical trials
2 medical researchers
Photo of Illinois CancerCare-Galesburg in GalesburgPhoto of Illinois CancerCare-Galesburg in GalesburgPhoto of Illinois CancerCare-Galesburg in Galesburg

Summary

Illinois CancerCare-Galesburg is a medical facility located in Galesburg, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Illinois CancerCare-Galesburg is involved with conducting 410 clinical trials across 473 conditions. There are 2 research doctors associated with this hospital, such as Bryan A. Faller and James L. Wade.

Area of expertise

1Cancer
Global Leader
Illinois CancerCare-Galesburg has run 148 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Illinois CancerCare-Galesburg has run 67 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at Illinois CancerCare-Galesburg

Breast Cancer
Cancer
Prostate Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Gastric Cancer
Bladder Cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Cancer
Esophageal Adenocarcinoma
Image of trial facility.

Hormone Therapy with or without Radiation

for Breast Cancer

This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Illinois CancerCare-Galesburg?
Illinois CancerCare-Galesburg is a medical facility located in Galesburg, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Illinois CancerCare-Galesburg is involved with conducting 410 clinical trials across 473 conditions. There are 2 research doctors associated with this hospital, such as Bryan A. Faller and James L. Wade.
Where is Illinois CancerCare-Galesburg located?
**Illinois CancerCare - Galesburg Location** - **Address:** 336 Home Blvd, Galesburg, IL 61401 - **Office Hours:** Monday-Friday, 8:00 AM - 5:00 PM - **Lab Hours:** Monday-Friday, 7:30 AM - 4:00 PM
Who should I call to ask about financial aid or insurance network?
**Illinois CancerCare-Galesburg Contact Information** **Financial Assistance:** - Phone: (800) 421-5700 - Email: OSF@ElevatePFS.com **Insurance:** - Phone: (309) 243-3000 or (866) 662-6564 - Address: 8940 N Wood Sage Rd, Peoria, IL 61615-7828 **General Information:** - Phone: (217) 383-3311
What insurance does Illinois CancerCare-Galesburg accept?
Illinois CancerCare-Galesburg accepts various insurance plans. For the most accurate and up-to-date information on accepted insurance plans, please contact the hospital directly or visit their website.
What awards or recognition has Illinois CancerCare-Galesburg received?
Illinois CancerCare-Galesburg, located in Galesburg, Illinois, is a leading hospital recognized by the Alliance for Clinical Trials in Oncology for its outstanding clinical research enrollment. It is a proud member of Heartland Cancer Research NCORP, renowned for leading the nation in cancer research participation. Additionally, it has earned recognition from the Quality Oncology Practice Initiative (QOPI®) Certification Program, highlighting its commitment to the highest standards of quality in outpatient hematology-oncology care.